ICU Medical, Inc. (NASDAQ:ICUI) Shares Acquired by Raymond James & Associates

Raymond James & Associates grew its position in ICU Medical, Inc. (NASDAQ:ICUIGet Rating) by 31.0% during the third quarter, Holdings Channel.com reports. The firm owned 100,181 shares of the medical instruments supplier’s stock after acquiring an additional 23,679 shares during the period. Raymond James & Associates’ holdings in ICU Medical were worth $15,087,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Comerica Bank grew its position in shares of ICU Medical by 21.8% in the 2nd quarter. Comerica Bank now owns 11,343 shares of the medical instruments supplier’s stock valued at $1,917,000 after buying an additional 2,030 shares during the last quarter. Victory Capital Management Inc. grew its position in shares of ICU Medical by 3.6% in the 2nd quarter. Victory Capital Management Inc. now owns 17,279 shares of the medical instruments supplier’s stock valued at $2,841,000 after buying an additional 597 shares during the last quarter. WCM Investment Management LLC grew its position in shares of ICU Medical by 50.6% in the 3rd quarter. WCM Investment Management LLC now owns 176,728 shares of the medical instruments supplier’s stock valued at $26,771,000 after buying an additional 59,403 shares during the last quarter. Oak Thistle LLC purchased a new position in shares of ICU Medical in the 2nd quarter valued at $256,000. Finally, Chartwell Investment Partners LLC grew its position in ICU Medical by 2.6% during the 2nd quarter. Chartwell Investment Partners LLC now owns 8,431 shares of the medical instruments supplier’s stock worth $1,386,000 after purchasing an additional 210 shares during the last quarter. 93.88% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at ICU Medical

In other news, VP Virginia Ruth Sanzone sold 325 shares of the firm’s stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $160.12, for a total value of $52,039.00. Following the completion of the sale, the vice president now owns 3,046 shares in the company, valued at approximately $487,725.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 7.30% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on ICUI. Raymond James downgraded shares of ICU Medical from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 8th. KeyCorp lowered their price objective on shares of ICU Medical from $225.00 to $200.00 in a research report on Tuesday, November 8th. Finally, StockNews.com raised shares of ICU Medical from a “sell” rating to a “hold” rating in a research report on Thursday, November 17th.

ICU Medical Trading Down 2.5 %

Shares of ICU Medical stock opened at $157.65 on Tuesday. ICU Medical, Inc. has a 1 year low of $128.90 and a 1 year high of $251.73. The company has a market capitalization of $3.78 billion, a P/E ratio of -101.06 and a beta of 0.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.17 and a current ratio of 2.45. The company’s fifty day moving average is $155.50 and its two-hundred day moving average is $159.69.

ICU Medical (NASDAQ:ICUIGet Rating) last released its earnings results on Monday, November 7th. The medical instruments supplier reported $1.53 EPS for the quarter, topping the consensus estimate of $1.15 by $0.38. ICU Medical had a negative net margin of 1.90% and a positive return on equity of 6.51%. The company had revenue of $597.86 million during the quarter, compared to analysts’ expectations of $562.90 million. Analysts forecast that ICU Medical, Inc. will post 5.18 earnings per share for the current year.

ICU Medical Profile

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

Read More

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIGet Rating).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.